Bank of America’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Bank of America’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-800	Closed	-$5K	–	7807
2014 Q4	$5K	Sell	800 -1,300	-62%	-$7.92K	﹤0.01%	7304
2014 Q3	$13K	Sell	2,100 -4,400	-68%	-$30.1K	﹤0.01%	7244
2014 Q2	$43K	Buy	6,500 +1,700	+35%	+$19.1K	﹤0.01%	6763
2014 Q1	$114K	Buy	+4,800	New	+$69.6K	﹤0.01%	5890

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Bank of America's ECYT Position: Q4 2018 in Review

Bank of America sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 21,777 shares — an estimated $387K sold.

Bank of America first reported a position in ECYT in Q2 2013 and held it in 22 quarters. The position peaked at $482K in Q1 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Bank of America reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Bank of America sold 21,777 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $387K.
Bank of America first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 22 quarters.
Bank of America's Endocyte, Inc. Common Stock position peaked at $482K in Q1 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Bank of America's 13F filing for Q4 2018, filed 14 Feb 2019.